the medication is available in combination with an estrogen and is not available alone it is used as a patch that is applied to the skin side effects of the combination of an estrogen and norelgestromin include menstrual irregularities headaches nausea abdominal pain breast tenderness mood changes and others norelgestromin is a progestin or a synthetic progestogen and hence is an agonist of the progesterone receptor the biological target of progestogens like progesterone it has very weak androgenic activity and no other important hormonal activity norelgestromin was introduced for medical use in 2002 it is sometimes referred to as a third generation progestin norelgestromin is marketed widely throughout the world it is available as a generic medication norelgestromin is used in combination with ethinylestradiol in contraceptive patches these patches mediate their contraceptive effects by suppressing gonadotropin levels as well as by causing changes in the cervical mucus and endometrium that diminish the likelihood of pregnancy norelgestromin is available only as a transdermal contraceptive patch in combination with ethinylestradiol the ortho evra patch is a 20 cm once weekly adhesive that contains 6 0 mg norelgestromin and 0 75 mg ethinylestradiol and delivers 150 g day norelgestromin and 35 g day